Drug Profile
Research programme: Alzheimer's and Parkinson's disease diagnostic agents - Bayer HealthCare Pharmaceuticals/TauRx
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma; WisTa Laboratories
- Developer Bayer HealthCare Pharmaceuticals; WisTa Laboratories
- Class Diagnostic agents; Imaging agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease; Parkinson's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease(Diagnosis) in Singapore
- 16 Jul 2016 No recent reports of development identified for preclinical development in Parkinson's-disease(Diagnosis) in Singapore
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals